Psilocybin induces delayed and dynamic changes in human sleep neurophysiology: Results from a randomized controlled trial of psilocybin assisted therapy in patients with comorbid major depressive and alcohol use disorder

Abstract Rationale Psilocybin has demonstrated therapeutic potential for major depressive disorder (MDD) and alcohol use disorder (AUD). However, its effects on sleep neurophysiology, particularly beyond the acute pharmacological period, remain poorly understood. Objectives To characterise the acute and post-acute temporal dynamics of sleep neurophysiology following psilocybin-assisted therapy in individuals with comorbid MDD and AUD. Methods In a randomised, placebo-controlled trial, 40 participants (psilocybin: n = 22; placebo: n = 18) underwent home-based sleep electroencephalographic (EEG) monitoring for three nights preceding and seven nights following administration. Longitudinal changes in spectral activity, sleep architecture, and sleep continuity were examined using nonlinear mixed-effects models. Results Significant treatment-by-night interactions revealed delayed, nonlinear alterations in sleep neurophysiology following psilocybin administration, with limited acute effects. NREM slow-wave activity (SWA), NREM sigma, REM sigma, and REM beta exhibited distinct curvilinear trajectories, reaching local minima (SWA) or maxima (sigma and beta) approximately 3–4 nights after administration. Sleep efficiency and total sleep time increased during the first three post-treatment nights, whereas sleep architecture, REM density, sleep onset latency, and delta sleep ratio remained largely unchanged. On the first post-treatment night, increased sleep efficiency was the only observed change, with no significant spectral or architectural alterations. Conclusions Psilocybin-assisted therapy induces delayed, dynamic alterations in human sleep neurophysiology extending beyond the acute pharmacological period. These findings suggest that sleep EEG may provide a sensitive measure of evolving neurophysiological processes following psilocybin administration.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11333812/v1
Primary Topic
Psychedelics and Drug Studies
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Psilocybin induces delayed and dynamic changes in human sleep neurophysiology: Results from a randomized controlled trial of psilocybin assisted therapy in patients with comorbid major depressive and alcohol use disorder

Caitlin M. DuPont, Frederick Streeter Barrett, Zarmeen Zahid, Patrick H. Finan et al.
2 links
Research Square
Psychedelics and Drug Studies
preprint

Psilocybin induces delayed and dynamic changes in human sleep neurophysiology: Results from a randomized controlled trial of psilocybin assisted therapy in patients with comorbid major depressive and alcohol use disorder

Caitlin M. DuPont, Frederick Streeter Barrett, Zarmeen Zahid, Patrick H. Finan, Matthew J. Reid, Luis Luna Martinez, Eli Weissman, Hongmin Dai
preprint en

Abstract

Abstract Rationale Psilocybin has demonstrated therapeutic potential for major depressive disorder (MDD) and alcohol use disorder (AUD). However, its effects on sleep neurophysiology, particularly beyond the acute pharmacological period, remain poorly understood. Objectives To characterise the acute and post-acute temporal dynamics of sleep neurophysiology following psilocybin-assisted therapy in individuals with comorbid MDD and AUD. Methods In a randomised, placebo-controlled trial, 40 participants (psilocybin: n = 22; placebo: n = 18) underwent home-based sleep electroencephalographic (EEG) monitoring for three nights preceding and seven nights following administration. Longitudinal changes in spectral activity, sleep architecture, and sleep continuity were examined using nonlinear mixed-effects models. Results Significant treatment-by-night interactions revealed delayed, nonlinear alterations in sleep neurophysiology following psilocybin administration, with limited acute effects. NREM slow-wave activity (SWA), NREM sigma, REM sigma, and REM beta exhibited distinct curvilinear trajectories, reaching local minima (SWA) or maxima (sigma and beta) approximately 3–4 nights after administration. Sleep efficiency and total sleep time increased during the first three post-treatment nights, whereas sleep architecture, REM density, sleep onset latency, and delta sleep ratio remained largely unchanged. On the first post-treatment night, increased sleep efficiency was the only observed change, with no significant spectral or architectural alterations. Conclusions Psilocybin-assisted therapy induces delayed, dynamic alterations in human sleep neurophysiology extending beyond the acute pharmacological period. These findings suggest that sleep EEG may provide a sensitive measure of evolving neurophysiological processes following psilocybin administration.

Research Square
Johns Hopkins University (US), University of Virginia (US)
Johns Hopkins University, Sleep Research Society
Good health and well-being
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon